Compare ALKS & AG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKS | AG |
|---|---|---|
| Founded | 1987 | 1979 |
| Country | Ireland | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 8.5B |
| IPO Year | 2012 | 2004 |
| Metric | ALKS | AG |
|---|---|---|
| Price | $50.21 | $15.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 3 |
| Target Price | ★ $43.43 | $21.92 |
| AVG Volume (30 Days) | 1.7M | ★ 9.5M |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 0.12% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,475,899,000.00 | N/A |
| Revenue This Year | $24.26 | $24.41 |
| Revenue Next Year | $4.47 | $10.68 |
| P/E Ratio | ★ N/A | $143.01 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $25.17 | $7.74 |
| 52 Week High | $55.67 | $32.00 |
| Indicator | ALKS | AG |
|---|---|---|
| Relative Strength Index (RSI) | 40.52 | 38.15 |
| Support Level | $27.78 | $10.46 |
| Resistance Level | $55.67 | $17.72 |
| Average True Range (ATR) | 1.79 | 0.68 |
| MACD | -0.79 | -0.02 |
| Stochastic Oscillator | 10.94 | 8.48 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
First Majestic Silver Corp is in the business of production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. The company owns four producing mines in Mexico, consisting of the Santa Elena Silver/Gold Mine, the San Dimas Silver/Gold Mine, the Los Gatos Silver Mine, and the La Encantada Silver Mine. It also owns the Jerritt Canyon Gold Mine in Nevada, USA. Additionally, the firm holds interests in the San Martin Silver Mine and the Del Toro Silver Mine, and several exploration-stage projects. The majority of the company's revenues are from the sale of precious metals contained in dore and concentrate form. It generates maximum revenue from the sale of silver, followed by gold, zinc, copper, and other metals.